+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

Cellular Signalling 19(12): 2487-2497

PI3K pathway exerts its function through its downstream molecule AKT in regulating various cell functions including cell proliferation, cell transformation, cell apoptosis, tumor growth and angiogenesis. PTEN is an inhibitor of PI3K, and its loss or mutation is common in human prostate cancer. But the direct role and mechanism of PI3K/PTEN signaling in regulating angiogenesis and tumor growth in vivo remain to be elucidated. In this study, by using chicken chorioallantoic membrane (CAM) and in nude mice models, we demonstrated that inhibition of PI3K activity by LY294002 decreased PC-3 cells-induced angiogenesis. Reconstitution of PTEN, the molecular inhibitor of PI3K in PC-3 cells inhibited angiogenesis and tumor growth. Immunohistochemical staining indicated that PTEN expression suppressed HIF-1alpha, VEGF and PCNA expression in the tumor xenographs. Similarly, expression of AKT dominant negative mutant also inhibited angiogenesis and tumor growth, and decreased the expression of HIF-1alpha and VEGF in the tumor xenographs. These results suggest that inhibition of PI3K signaling pathway by PTEN inhibits tumor angiogenesis and tumor growth. In addition, we found that AKT is the downstream target of PI3K in controlling angiogenesis and tumor growth, and PTEN could inhibit angiogenesis by regulating the expression of HIF-1 and VEGF expression through AKT activation in PC-3 cells.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 021516318

Download citation: RISBibTeXText

PMID: 17826033

DOI: 10.1016/j.cellsig.2007.07.025

Related references

PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells. Molecular and Cellular Biochemistry 331(1-2): 161-171, 2010

CircVRK1 regulates tumor progression and radioresistance in esophageal squamous cell carcinoma by regulating miR-624-3p/PTEN/PI3K/AKT signaling pathway. International Journal of Biological Macromolecules 2018, 2018

MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer. International Journal of Oncology 21(3): 469-475, 2002

PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochimica et Biophysica Acta 1784(1): 150-158, 2007

PI3K/PTEN signaling in angiogenesis and tumorigenesis. Advances in Cancer Research 102: 19-65, 2009

PI3K/AKT/PTEN Signaling as a Molecular Target in Leukemia Angiogenesis. Advances in Hematology 2012: 843085, 2012

PTEN Regulates PI(3,4)P 2 Signaling Downstream of Class I PI3K. Molecular Cell 68(3): 566-580.E10, 2017

p85 plays a critical role in controlling flux through the PI3K/PTEN signaling axis through dual regulation of both p110 (PI3K) and PTEN. Cell Cycle 9(11): 2055-2056, 2011

Relations of synovial angiogenesis and PTEN/PI3K/AKT signaling pathway in rats with adjuvant arthritis. Zhongguo Gu Shang 28(1): 71-74, 2015

miR-363-3p is activated by MYB and regulates osteoporosis pathogenesis via PTEN/PI3K/AKT signaling pathway. In Vitro Cellular and Developmental Biology. Animal 2019, 2019

Astragaloside IV exerts angiogenesis and cardioprotection after myocardial infarction via regulating PTEN/PI3K/Akt signaling pathway. Life Sciences 2019, 2019

PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro. Dna Repair 7(10): 1746-1756, 2008

The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis. Genes and Development 19(17): 2054-2065, 2005

Mitochondrial-derived hydrogen peroxide regulates PI3K signaling via PTEN oxidation. Free Radical Biology & Medicine 35(Supplement 1): S62, 2003

Maf1 is a novel target of PTEN and PI3K signaling that negatively regulates oncogenesis and lipid metabolism. Plos Genetics 10(12): E1004789, 2015